Author: Tom Wilemon
Eng stresses need for clinical trial support at cancer forum
Mar. 16, 2023—Vanderbilt's Cathy Eng, MD, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum.
Nicole Kidman and Keith Urban gift supports breast cancer clinical trials at Vanderbilt-Ingram Cancer Center
Mar. 7, 2023—Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.
Eng invited to White House Cancer Moonshot forum
Mar. 2, 2023—Vanderbilt's Cathy Eng, MD, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.
Trial seeks to expand therapies for biliary cancers
Feb. 23, 2023—A Vanderbilt clinical trial seeks to optimize the effect of immunotherapies for patients with biliary tract cancers who have already progressed on first-line therapy.
Patient undergoes novel therapy to treat pancreatic cancer
Feb. 16, 2023—Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.
Tindle authors NCI guidance on treatment of cancer patient who smoke
Feb. 16, 2023—Vanderbilt's Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute.
‘Biopsy Queen’ reaches milestone number of procedures
Feb. 9, 2023—Vanderbilt-Ingram Cancer Center's Krista Kuhnert-Gainer, ACNP has performed more than 20,000 bone marrow biopsies since 1996.
Vanderbilt-Ingram joins CancerLinQ quality initiative
Feb. 9, 2023—Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.
Berlin named director of Division of Hematology and Oncology
Feb. 6, 2023—Jordan Berlin, MD, has been named director of Vanderbilt’s Division of Hematology and Oncology.
Surgeons target pancreatic cancer with electrons using new technology
Jan. 19, 2023—Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.
New approach outperforms existing cancer susceptibility models
Jan. 5, 2023—A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.
Lovly receives Asclepios Award from GO2 for Lung Cancer
Dec. 8, 2022—Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.
